Cytosine base editors (CBEs) are molecular machines which enable efficient and programmable reversion of T•A to C•G point mutations in the human genome without induction of DNA double strand breaks1, 2. Recently, the foundational cytosine base editor (CBE) 'BE3', containing rAPOBEC1, was reported to induce unguided, genomic DNA3, 4 and cellular RNA5 cytosine deamination when expressed in living cells. To mitigate spurious off-target events, we developed a sensitive, high-throughput cellular assay to select next-generation CBEs that display reduced spurious deamination profiles relative to rAPOBEC1-based CBEs, whilst maintaining equivalent or superior on-target editing frequencies. We screened 153 CBEs containing cytidine deaminase enzymes with diverse sequences and identified four novel CBEs with the most promising on/off target ratios. These spurious-deamination-minimized CBEs (BE4 with either RrA3F, AmAPOBEC1, SsAPOBEC3B, or PpAPOBEC1) were further optimized for superior on-and off-target DNA editing profiles through structure-guided mutagenesis of the deaminase domain. These next-generation CBEs display comparable overall DNA on-target editing frequencies, whilst eliciting a 10-to 49-fold reduction in C-to-U edits in the transcriptome of treated cells, and up to a 33-fold overall reduction in unguided off-target DNA deamination relative to BE4 containing rAPOBEC1. Taken together, these next-generation CBEs represent a new collection of base editing
tools for applications in which minimization of spurious deamination is desirable and high on-target activity is required.
Base editors are gene editing tools for efficient and programmable correction of pathogenic point mutations for both research and therapeutic applications1, 6. Unlike CRISPR-associated nuclease gene approaches, base editors do not create double-stranded DNA breaks and therefore minimize the formation of undesired editing byproducts, including insertions, deletions, translocations, and other large-scale chromosomal rearrangements1, 2, 6, 7. Cytosine base editors (CBEs) are comprised of a cytosine deaminase fused to an impaired form of Cas9 (D10A) which is tethered to one (BE3) or two (BE4) monomers of uracil glycosylase inhibitor (UGI)8. This architecture of CBEs enables the conversion of C•G base pairs to T•A base pair in human genomic DNA, through the formation of an uracil intermediate1.
Although CBEs lead to robust on-target DNA base editing efficiency in a variety of contexts (e.g. rice, wheat, human cells and bacteria, reviewed here2), recent reports have demonstrated that treatment of cells with high doses of BE3 can lead to low, but detectable spurious cytosine deamination in both DNA3, 4 and cellular RNA5 which occur in an unguided fashion, independent of the sgRNA sequence used. Specifically, in treatment of rice with BE3, "substantial" genome-wide spurious C to T SNVs occurred, above background, and enriched in genic regions3. Furthermore, in a study conducted by Zuo and coworkers that evaluated spurious DNA editing events resultant from microinjection of BE3 in mouse embryos, a mutation rate of one in ten million bases was detected, which resulted in approximately 300 additional single nucleotide variants (SNVs) compared to untreated cells4. Even though this rate of mutation is within the range that occurs naturally in mouse and human somatic cells9, 10, given the therapeutic importance of CBEs, we were motivated to develop next-generation CBEs that function efficiently at their on-target loci with minimal off-target spurious deamination relative to the foundational base editors, BE3/4, which contain rAPOBEC1.
Since both the reported DNA3, 4 and RNA5 off-target deamination events result from unguided, Cas9-independent deamination events, we hypothesized that these undesired editing byproducts were caused by the intrinsic ssDNA binding affinities of the cytosine deaminase itself. The canonical CBE base editor BE3, used in the aforementioned spurious deamination reports3-5, contains an N-terminal cytidine deaminase rAPOBEC1, an enzyme that has been extensively characterized to deaminate both DNA11,12 and RNA10,13 when expressed in mammalian, avian, and bacterial cells. Indeed, CBEs containing rAPOBEC-1 (BE3, BE4, BE4max1, 8, 14) are widely utilized base editing tools due to their overall high on-target DNA editing efficiencies, but it has not been extensively evaluated whether existing, and/or engineered deaminases might provide similar high on-target DNA editing efficiency whilst preserving a minimized unguided, deaminase dependent, off-target profile.
In order to screen a wide range of next-generation CBE candidates for preferred on-and offtarget editing profiles, we established a high-throughput assay to evaluate unguided ssDNA deamination. Since spurious deamination in the genome has been reported to occur most frequently in highly transcribed regions of the genome3,4, it is tempting to hypothesize that rAPOBEC1 is most able to access transiently available ssDNA that is generated during DNA replication or transcription ( Fig.   1a ). Therefore, we sought to mimic the availability of genomic ssDNA by presenting this substrate via a secondary R-loop generated by an orthogonal SaCas9/sgRNA complex and quantified the amount of unguided editing on this ssDNA substrate with fully intact CBEs ( Fig. 1b) . Here, "in cis" activity refers to on-target DNA base editing and "in trans" activity refers to base editing in the secondary SaCas9induced R loop, to which the base editor is not directed by its own sgRNA, mimicking the transient, unguided off-targeting editing events in the genome observed in mice4 and rice3.
Crucially, we assessed the validity and sensitivity of this on-and off-target editing evaluation assay using BE4 and ABE7.10 treated cells. Previously, it has been shown that cells treated with BE3 (CBE with rAPOBEC-1), but not ABE7.10, display an increase in unguided, spurious deamination in genomic DNA3, 4. Consistent with these findings, our assay also showed that cells treated with BE4 (with rAPOBEC1) led to much greater levels of in trans editing than ABE7.10 ( Fig. 1c-d) . The sensitivity of the assay is demonstrated by the result that treatment of cells with an ABE7.10 variant led to >0.5% A-to-G editing at 20 of 33 loci tested in trans, up to a maximum of 25% ( Fig. 1d) . We speculate that the sensitivity of our assay may be attributed to both the presentation of the ssDNA substrate via stable Rloop generated by catalytically impaired Sa-Cas9 nickase with two UGI protomers attached (Sa-Cas9(D10A)-UGI-UGI)15 and the fact that the deamination events are measured by Illumina amplicon sequence with at least 5,000 reads per sample.
First, we used this cellular assay to test if mutagenesis of deaminases can be used to reduce in trans activity, which has been previously shown as a method to reduce RNA off-target editing and bystander editing5, 16, 17 . Utilizing a homology model of rAPOBEC1 ( Supplementary Fig. 1 ), based on hA3C crystal structure18, we identified 15 residues that we predicted to be important for ssDNA binding and 8 that affect catalytic activity. Through mutagenesis of these 23 residues, we identified 7 highfidelity (HiFi) mutations in rAPOBEC1 (R33A, W90F, K34A, R52A, H122A, H121A, Y120F) that reduce in trans activity without dramatically reducing in cis activity ( Supplementary Fig. 2 ). Notably, mutations of R52, H122, H121, Y120 in rAPOBEC1 have not been reported previously as methods to reduce unwanted editing activity. However, BE4 (containing rAPOBEC1) with single or double HiFi mutations led to either retention of some in trans activity or dramatically reduced in cis activity in cells ( Supplementary Fig. 3 ), which prevents their broad application as a therapeutic reagent.
Consequently, we began a screening campaign to survey alternative cytidine deaminases with improved editing profile in base editing context.
We began our search for next-generation CBEs with a preliminary screen of CBEs containing cytidine deaminases from well-characterized families including APOBEC1, APOBEC2, APOBEC3, APOBEC4, AID, CDA, etc. Three APOBEC1s (hAPOBEC1, PpAPOBEC1, OcAPOBEC1, MdAPOBEC1) showed a high in cis/in trans ratio at select sites ( Fig. 2a and Supplementary Fig. 4) and, of note, primary sequence alignment of the examined APOBEBC1s with rAPOBEC1 reveal a common phenylalanine substitution at position 120 ( Supplementary Fig. 5 ), a mutation identified from our structure-guided mutagenesis (Y120 in rAPOBEC1). Conversely, BE4 constructs containing deaminases which yield high in trans activity (rAPOBEC1, mAPOBEC1, maAPOBEC1, hA3A) all contain tyrosine at this position ( Supplementary Fig. 5 ). This observation supports the predicted function of HiFi mutations and might provide explanation to the different behavior from these two groups of cytidine deaminases. BE4 variants containing PpAPOBEC1 deaminase (68% sequence identify as rAPOBEC1) showed comparable on-target DNA activity to BE4 and on average 2.3-fold decrease in in trans activity across 10 sites tested (Supplementary Fig. 6 ). HiFi mutations of PpAPOBEC1 were predicted based on sequence alignment (Supplement Fig. 5 ), and BE4 with PpAPOBEC1 containing either H122A or R33A mutations display desirable editing profiles ( Supplementary Fig. 6 ), with 0.75x and 0.74x average in cis activities and 33 and 13-fold reduction in average in trans activities as compared to BE4 with rAPOBEC1, respectively. Together, these data make BE4 with PpAPOBEC1 the preferred CBE from our first round of screening.
Encouraged by these results, a more exhaustive screen of 43 APOBEC-like cytidine deaminases with broad sequence diversity was performed ( Fig. 2a, Supplementary Fig.6 and Supplementary Note 1). We performed a protein BLAST with hAPOBEC1 as the query sequence to generate a sequence similarity network (SSN) with the top 1000 sequences, enabling us to select cytosine deaminases with broad sequence diversity. From this screening campaign, three constructs (BE4s with RrA3F, AmAPOBEC1, or SsAPOBEC3B) showed robust on-target DNA editing activities that are comparable to BE4 (with rAPOBEC1) with 1.05x, 0.71x, and 0.91x average in cis activities respectively and 2.3, 13.5, and 6.1-fold decrease on average in trans activity ( Fig. 2b and Supplementary Fig. 8-10 ). Notably, BE4 constructs with either RrA3F or SsAPOBEC3B displayed comparably higher editing frequencies at GC target sites that are not well edited with BE4 (with rAPOBEC1) (Supplementary Fig.   8 ). Additionally, we observed variations in editing windows of in cis and in trans editing with these editors (Supplementary Fig. 9 ). Finally, we expanded our screen again to interrogate a new set of 80 putative cytidine deaminases from other protein families but none of these deaminases showed > 0.5% editing efficiency in the context of BE4 at the site tested.
We further optimized the BE4 editors (with RrA3F, AmAPOBEC1, or SsAPOBEC3B) by rational mutagenesis Supplementary Fig. 2-3) . We installed rationally designed HiFi mutations from our rAPOBEC1 studies based on homology model ( Supplementary Fig. 11 ) into these four BE4 editors.
Two mutants (RrA3F F130L and SsAPOBEC3B R54Q) showed further improved editing profile ( Fig.   2b and Supplementary Fig. 9) , with 1.03x and 0.90x average in cis activities and 3.8 and 19.2-fold decrease in average to in trans activities, respectively, relative to BE4 containing rAPOBEC1. Together these engineered, alternative deaminase BE4 constructs offer high in cis with reduced in trans editing activity.
With these next-generation CBEs in hand we evaluated a sub-set [BE4 with PpAPOBEC1 (wt, H122A or R33A), RrA3F (wt), AmAPOBEC1 (wt), SsAPOBEC3B (wt)], to further characterize their offtarget RNA activity. Plasmid-based overexpression of BE3 containing rAPOBEC1, induced "extensive transcriptome-wide RNA cytosine deamination", and as such we evaluated our next-generation CBEs in a similar assay5. Satisfyingly, all six next-generation BE4s tested showed > 20-fold reduction in Cto-U edits as compared to BE4 with rAPOBEC1 ( Fig. 3a) . Notably, treatment of cells with BE4s containing RrA3F or SsAPOBEC3B, led to frequencies of C-to-U edits that are comparable to cells treated with nCas9 (D10A) alone. Additionally, deep-sequencing analysis of selected regions in the transcriptome reveal C-to-U editing outcomes consistent with whole transcriptome sequencing data ( Fig. 3b) . Taken together, these data suggest that the next-generation CBEs result in reduced spurious deamination in the cellular transcriptome as compared to BE3 or 4 containing rAPOBEC1.
Next, we evaluated guide-dependent DNA off-target editing at known Cas9 off-target loci19 associated with 3 SpCas9 sgRNAs. Guide-dependent off-target activities of BE4 with PpAPOBEC1 were similar to BE4 with rAPOBEC1 ( Fig. 3c and Supplementary Fig. 12a-d) . Interestingly, some next-generation CBEs showed reduced guide-dependent off-target editing for at least one sgRNA tested, and our HiFi mutations also reduced guide-dependent off-target editing efficiency ( Fig. 3c and   Supplementary Fig. 12a-d) . For example, at three of the most highly edited off-target sites (Hek2, site1; Hek3, site3; Hek4, site1), cells treated with BE4 containing AmAPOBEC1 engendered at least 18.8, 26.7, and 3.3-fold reduction in guide-dependent off-target editing than BE4 with rAPOBEC1 respectively (Fig. 3c) . Notably, BE4 with PpAPOBEC1 H122A showed more than a 3-fold reduction in guide-dependent off-target editing than BE4 with PpAPOBEC1 at these three sites with no observable decrease in on-target editing (Fig 3c) . These data indicate that next-generation CBEs can yield more favorable or equivalent guided off-target editing profiles as compared to BE4 containing rAPOBEC1.
Furthermore, to validate that base editing outcomes resultant from our next-generation CBES were not due to differences in editor expression, we quantified the amount of protein produced from cells transfected with our next-generation CBEs and BE4 and show that next-generation CBE protein levels are comparable to amounts observed for BE4 (See Supplementary Note 2) .
As a secondary evaluation of unguided DNA off-target editing, we developed an in vitro assay, utilizing free, synthetic ssDNA and CBE protein, as a further validation of our results obtained with the in cis/in trans assay described above. Total cell lysate containing base editor proteins was harvested from cells, normalized, and mixed with two synthesized oligos that contain 11 or 13 cytosines between cytosine-free adaptors, covering all NC motifs. In this assay, six next-generation CBE editors showed an average of 1.0-3.4% C-to-U editing efficiency as compared to BE4 with rAPOBEC1 which has an average of 9.4% C-to-U (data are across all 24 Cs contained within the two substrates ( Fig. 3d and   Supplementary Fig. 13 ). The increased ssDNA editing activity of BE4 containing rAPOBEC1, relative to our next-generation CBEs, was further supported by a time-course assay in which both the absolute level and apparent rate of deamination by BE4 with rPOABEC1 was greater than our next-generation CBEs (Fig. 3e) . We observed 12 to 37-fold more C-to-U containing ssDNA at 5 min and 2.2 to 9.6-fold more product formed at 6 h by BE4 with rAPOBEC1 compared to our next-generation CBEs (Fig. 3e) .
Together these data suggest that we have discovered alternative, next-generation deaminases with reduced activity on exposed ssDNA, a feature that is especially important for therapeutic application of base editors.
Here, we report several new next-generation CBEs with minimized un-guided RNA and DNA offtarget editing through a screening of a variety of sequence diverse cytidine deaminases. We developed two high-throughput assays to evaluate unguided ssDNA editing efficiency and from a total of 153 deaminases screened, four enzymes (PpAPOBEC1, RrA3F, AmAPOBEC1, and SsAPOBEC3B) were identified to have reduced off-target editing and high on-target editing. Together with structure-guided mutagenesis on these four constructs we highlight 8 next-generation CBEs (BE4-PpAPOBEC1, BE4-PpAPOBEC1 H122A, BE4-PpAPOBEC1 R33A, BE4-RrA3F, BE4-RrA3F F130L, BE4-AmAPOBEC1 and BE4-SsAPOBEC3B and BE4-SsAPOBEC3B R54Q) with reduced to minimized off-target editing efficiency and comparable on-target editing efficiency to BE4 containing rAPOBEC1. Transcriptomewide RNA deamination associated with expression of these editors was comparable to that of nCas9(D10A)-2xUGI, whilst the average on-target editing was about 3.9-to 5.7-fold higher than BE4 with rAPOBEC1 with previously published SECURE mutations (R33A, K34A)5. Our next-generation CBEs also showed ~2 to 9-fold reduction in editing efficiency on free ssDNA oligos in in vitro enzymatic assay. Since the most efficient next-generation CBE can be site-and application-dependent, we recommend evaluating each of our eight next-generation CBEs for every new target of interest.
However, if experimental design necessitates only one next-generation CBE be used, we advise researchers to utilize either BE4 containing PpAPOBEC1 H122A or BE4 containing RrA3F instead of the foundational BE4 with rAPOBEC1 to minimize aforementioned spurious DNA and RNA deamination events associated with rAPOBEC1. Next-generation CBEs reported here are superior replacements for the canonical BE4 and we anticipate that they will be invaluable tools for the genome editing field.
Materials and Methods

General Methods:
Constructs used in this study were obtained by USER assembly, Gibson assembly, or synthesized by Genscript. Gene fragments used for PCR were purchased as mammalian codonoptimized gene fragments from IDT. PCR were performed with primers ordered from IDT using either (v/v) fetal bovine serum (A31606-02, Thermo Fisher Scientific) following culture method on ATCC website. Cell culture incubator was set to 37 ℃ with 5% CO2. Cells were tested negative for mycoplasma after receipt from supplier. After ~64 h of incubation, cells were harvested. For NGS amplicon sequencing, media was aspirated and 50-100 μL QuickExtract™ DNA Extraction Solution (Lucigen) were added to each well. gDNA extraction was performed according to manufacturer's instructions; For RNA extraction (48 well-plate), 300 μL RTL plus buffer (RNasy Plus 96 kit, Qiagen) was added to each well. RIPA buffer (100 μL per well, ThermoFisher Scientific) was used to lysis the cells for protein quantification purpose. For in vitro enzymatic assays (48 well-plate), each well of cells were lysed with 100 μL M-per buffer (ThermoFisher Scientific).
Transfection conditions and harvest of cells
Next generation sequencing (NGS) and data analysis for on-target and off-target DNA editing
Genomic DNA samples were amplified and prepared for high throughput sequencing as Supplementary Table 3 . 
Data availability:
Core next-generation CBEs described in this work are deposited on Addgene. High-throughput sequencing data will be deposited in the NCBI Sequence Read Archive (PRJNA595157) upon publication.
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All software tools used for data analysis are publicly available. Detailed information about versions and parameters used, as well as shell commands, are provided in Supplementary Note 3 and 4. Figure 1 . Unguided ssDNA deamination and in cis/in trans assay. a, potential ssDNA formation in the genome during transcription or replication. b, experimental design of in cis/in trans assay. Separate constructs encoding SaCas9, gRNA for SaCas9 and base editor were used to transfect HEK293T cells. in cis and in trans activity was measured in different transfections but at the target site with NGGRRT PAM sequence. c, in cis/in trans activities of BE4 with rAPOBEC1 and d, ABE7.10 variant at 33 genomic sites. Blue bars indicate in cis, on target editing, red bars indicate in trans editing. Base editing efficiencies were reported for the most edited base in the target sites. Values and error bars reflect the mean and s.d. of three independent biological replicates. Figure 2 . Deaminase similarity network and identified next generation CBEs with high in cis activities and reduced in trans activities compared to BE4 with rAPOBEC1. A, Similarity network of APOBEC-like deaminases. This network was constructed using methods described in Supplementary Note 1.The size of the dots represents the average in cis activity; the color of the dots represents the average in trans/in cis ratio. Average in cis/in trans activity was calculated based on three independent biological replicates on target site 1, 4, 6, and the actual editing efficiencies are displayed in Supplementary Fig.4 and Supplementary Fig.7 . b, Comparison of in cis and in trans editing frequencies of mammalian cells treated with next generation CBEs (BE4 with PpAPOBEC1[wt, H122], RrA3F [wt, F130L], AmAPOBEC1, SsAPOBEC3B[wt, R54Q] at 10 genomic sites. Base editing efficiencies were reported for the most edited base in the target sites. Values and error bars reflect the mean and s.d. of 4 independent biological replicates. Figure 3 . Next-generation CBEs with reduced DNA and RNA off-target editing relative to BE4 in mammalian cells. a, Whole transcriptome sequencing b, and target RNA sequencing of Hek293T cells expressing spurious deamination minimized cytosine base editors. c, percentage of C to T editing at know guided off-target sites. d, percentage of C to T editing in in vitro enzymatic assay on single strand DNA substrates. C to U editing of core next-generation CBEs on ssDNA substrates. Colored dots represent NC local sequence context of edit. Black line indicates average editing efficiency across target cytosines in substrates. e, time course of product formation in in vitro enzymatic assay from cell lysates containing selected CBEs. The sequences of the oligos used in d and e are listed in Supplementary Table S3 . Values and error bars reflect the mean and s.d. of independent biological triplicates (a,b,c) or duplicates (d, e).
